ROCO
4116
Market cap52mUSD
Jul 09, Last price
37.90TWD
1D
-1.17%
1Q
-4.17%
Jan 2017
-0.13%
IPO
419.18%
Name
BenQ Medical Technology Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
BenQ Medical Technology Corporation operates as a multifaceted entity in the healthcare sector, providing a comprehensive range of services for medical equipment and consumables. This includes their manufacturing, assembly, maintenance, and repair, alongside their distribution through wholesale, retail, and leasing channels. The company serves markets across Taiwan, Mainland China, India, and other international regions. Its product portfolio features key offerings such as operating tables, surgical lights, ultrasound systems, medical and protective masks, medical display monitors, and IQOR integrated systems. Beyond its core medical device business, BenQ Medical also diversifies its operations into the wholesale and retail of information software, the sale of medical pharmaceuticals, the provision of management consultation services, and general trading activities. Established in 1989, the company initially operated as Trident Medical Corp. It rebranded to BenQ Medical Technology Corporation in June 2011 and is headquartered in Taipei, Taiwan.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||